Tolvaptan, a vasopressin type-2 receptor antagonist, is utilized to ameliorate fluid retention following cardiac surgery. However, the optimal timing of tolvaptan administration considering novel biomarkers remains unknown. We prospectively included patients who underwent surgery between 2016 and 2020. measured perioperative trends free water reabsorption mediators including plasma arginine uri...
